Acurx Pharmaceuticals Inc (ACXP)
1.93
-0.04
(-2.03%)
USD |
NASDAQ |
May 08, 16:00
1.93
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals Cash from Operations (Quarterly): -4.198M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.198M |
| September 30, 2023 | -2.094M |
| June 30, 2023 | -1.577M |
| March 31, 2023 | -1.933M |
| December 31, 2022 | -1.496M |
| September 30, 2022 | -2.180M |
| June 30, 2022 | -1.991M |
| March 31, 2022 | -1.876M |
| Date | Value |
|---|---|
| December 31, 2021 | -1.500M |
| September 30, 2021 | -2.637M |
| June 30, 2021 | -0.3298M |
| March 31, 2021 | -0.5471M |
| December 31, 2020 | -0.9598M |
| September 30, 2020 | -0.7588M |
| June 30, 2020 | -0.7338M |
| March 31, 2020 | -0.8993M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.198M
Minimum
Dec 2023
-0.3298M
Maximum
Jun 2021
-1.607M
Average
-1.538M
Median
Cash from Operations (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | -22.34M |
| Seelos Therapeutics Inc | -1.911M |
| PetVivo Holdings Inc | -1.290M |
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 4.620M |
| Free Cash Flow | -9.801M |
| Free Cash Flow Per Share (Quarterly) | -0.3033 |
| Free Cash Flow Yield | -40.09% |